Continuous, comprehensive and crucial care: The role of the CNS in the metastatic castration-resistant prostate cancer patient pathway.
Br J Nurs
; 27(Sup4b): S1-S8, 2018 Feb 01.
Article
em En
| MEDLINE
| ID: mdl-29461871
ABSTRACT
Several treatment options are now available to men with metastatic castration-resistant prostate cancer (mCRPC). While survival rates for mCRPC continue to improve, patients are faced with increasingly complex treatment pathways and decisions. The clinical nurse specialist (CNS) plays a crucial role in navigating patients with mCRPC through their treatment pathway and fulfils a number of key responsibilities, including providing holistic care and support to patients and their families, educating and communicating with them in a timely and effective manner, and liaising with other healthcare professionals to seamlessly coordinate patient treatment. However, increasing patient caseloads and administrative duties are leaving CNSs with little time to fulfil their supportive role. Additional resources are needed in order to both promote and preserve this supportive role, thus ensuring that mCRPC patients receive the best possible care.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Procedimentos Clínicos
/
Padrões de Prática em Enfermagem
/
Neoplasias de Próstata Resistentes à Castração
/
Enfermeiros Clínicos
Tipo de estudo:
Guideline
/
Prognostic_studies
Limite:
Humans
/
Male
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article